Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Diet changes hormone levels in pregnant ewes by affecting metabolism, not placental synthesis.

A balanced diet is crucial for normalizing hormone levels and managing obesity-related issues.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Allopregnanolone changes gene expression in glioblastoma cells.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Some Thai plants, especially Carthamus tinctorius, could help prevent hair loss and promote hair growth without adverse effects.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Some vegetables from Northern Thailand show promise for health benefits, including hair loss treatment and antioxidant properties.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

PCOS is common in women, often treated with lifestyle changes and oral contraceptives.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.